Pfizer and BioNTech Seek Vaccine Approval for Those Ages 12-15
2021-12-17 1
A successful Phase 3 clinical trial has led to the Pfizer and BioNTech to seek full vaccine approval for people between 12 and 15 years-old. Veuer’s Maria Mercedes Galuppo has the story.
